✦ LIBER ✦

PCV22 COST EFFECTIVENESS ANALYSIS OF BOSENTAN FORTHE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN SOUTH KOREA

✍ Scribed by TJ Lee; J Kim; HS Sohn; D Kim

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV17 Cost-Effectiveness Analysis of Bos

✍ V. Omelyanovsky; M. Avxentyeva; I. Krysanov; S. Goryaynov; O. Ivakhnenko; F.M. T 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV34 A COST-EFFECTIVENESS ANALYSIS OF O

✍ M Lamotte; L Annemans; R Van Loy; W Koch 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

PCV88 THE COST EFFECTIVENESS OF AMBRISEN

✍ S Redmond; D Bozkaya 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCV38 BOSENTAN IS A COST-EFFECTIVE TREAT

✍ MD Stevenson; FC MacDonald; J Langley; RL Akehurst 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PCV7 CLINICAL EFFECTIVENESS OF BOSENTAN,

✍ L Becla; B Osiska; K Malottki; I Lipska 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

PCV117 COST-UTILITY OF BOSENTAN IN THE F

✍ EJ Soini; MD Stevenson; JA Martikainen; RL Akehurst 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB